Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-75
SponsorCairo University

About this trial

Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Eustachian Tube Dysfunction (chronic obstructive form)

unilateral ear affetion

senior patients

chronci affection more than 3 months

Disqualifiers

obesity

cardiac probelms repsiratory problems

Trial design

Design model

Parallel

Treatments tested in this trial

  • Buteyko breathing

    Other intervention

    twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.

  • usual care

    Other intervention

    twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Eustachian Tube Dysfunction Questionnaire

it will be used to asses symptoms of Eustachian Tube Dysfunction

Time frame
it will be measured after 2 weeks

Secondary outcomes

1

systolic blood pressure

it will be measured manually by manual sphygmomanometer

Time frame
it will be measured after 2 weeks
2

diastolic blood pressure

it will be measured manually by manual sphygmomanometer

Time frame
it will be measured after 2 weeks
3

respiratory rate

it will assess breath number per minute

Time frame
it will be measured after 2 weeks
4

pulse rate

it will assess pulse number per minute from radial artery

Time frame
it will be measured after 2 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.